📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: XBiotech

1.1 - Company Overview

XBiotech Logo

XBiotech

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of antibody therapy development as a biopharmaceutical company.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to XBiotech

Numab Therapeutics Logo

Numab Therapeutics

HQ: Switzerland Website
  • Description: Provider of antibody-based therapeutics for severe diseases, including chronic inflammation and cancer, leveraging a plug-and-play platform to predictably yield ready-to-develop multispecific biotherapeutics. Offerings include NM26 for atopic dermatitis, NM49 for cancer, and λ-Cap (stable human antibody fragments) and MATCH (modular scaffolding for multispecific formats) technologies.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Numab Therapeutics company profile →
Araclon Biotech Logo

Araclon Biotech

HQ: Spain Website
  • Description: Provider of pharmacological and biotechnological products and services focused on Alzheimer’s disease. Offers ABtest Service for plasma analysis of amyloid peptides Aβ40 and Aβ42 to aid early diagnosis, and ABvac40, an active immunotherapy vaccine targeting Aβ40 to prevent or delay symptom onset. Engages in scientific investigation, creation, and commercialization of diagnostics, pharmacological treatment models, and related patents.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Araclon Biotech company profile →
Y-mAbs Therapeutics Logo

Y-mAbs Therapeutics

HQ: United States Website
  • Description: Provider of innovative cancer treatments and support services, including FDA-approved DANYELZA (naxitamab-gqgk) for relapsed or refractory high-risk neuroblastoma in bone or bone marrow; clinical trials for investigational therapies (naxitamab, omburtamab, GD2-SADA); expanded access programs; Y-mAbs Connect for access, insurance and financial support; and patient and family resources.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Y-mAbs Therapeutics company profile →
Adheron Therapeutics Logo

Adheron Therapeutics

HQ: United States Website
  • Description: Provider of biotechnology therapeutics that disrupt cell adhesion to treat a variety of diseases, based on pioneering work from Dr. Michael Brenner’s lab at Brigham and Women’s Hospital and Harvard Medical School, including work around Cadherin-11 (Cad-11), a cellular adhesive.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Adheron Therapeutics company profile →
Alzamend Neuro Logo

Alzamend Neuro

HQ: United States Website
  • Description: Provider of biotech therapies for Alzheimer's disease that develops and commercializes drugs, treatments, and cures. Includes AL001, an ionic cocrystal delivering lithium via lithium/proline/salicylate for Alzheimer's, bipolar disorder, major depressive disorder, and PTSD; and ALZN002, a cell-based therapeutic vaccine using a mutant-peptide sensitized cell to restore the patient's immune system's ability to combat Alzheimer's.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Alzamend Neuro company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for XBiotech

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to XBiotech

2.2 - Growth funds investing in similar companies to XBiotech

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for XBiotech

4.2 - Public trading comparable groups for XBiotech

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to XBiotech

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About XBiotech

What does XBiotech do?

XBiotech is a provider of antibody therapy development as a biopharmaceutical company.

Who are XBiotech's competitors?

XBiotech's competitors and similar companies include Numab Therapeutics, Araclon Biotech, Y-mAbs Therapeutics, Adheron Therapeutics, and Alzamend Neuro.

Where is XBiotech headquartered?

XBiotech is headquartered in United States.

How many employees does XBiotech have?

XBiotech has 1,000 employees 🔒.

When was XBiotech founded?

XBiotech was founded in 2010 🔒.

What sector and industry vertical is XBiotech in?

XBiotech is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for XBiotech

Who are the top strategic acquirers in XBiotech's sector and industry

Top strategic M&A buyers and acquirers in XBiotech's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for XBiotech?

Top strategic M&A buyers groups and sectors for XBiotech include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in XBiotech's sector and industry vertical

Which are the top PE firms investing in XBiotech's sector and industry vertical?

Top PE firms investing in XBiotech's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in XBiotech's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in XBiotech's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in XBiotech's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to XBiotech include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in XBiotech's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for XBiotech?

The key public trading comparables and valuation benchmarks for XBiotech include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for XBiotech for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for XBiotech with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in XBiotech's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for XBiotech with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in XBiotech's' sector and industry vertical?

Access recent funding rounds and capital raises in XBiotech's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for XBiotech